Hemostasis and Thrombosis in Major Liver Resection

Andrea J. Cross; Saxon J. Connor

doi:10.1055/s-0034-1398385

Seminars in Thrombosis and Hemostasis, Table of Contents

Semin Thromb Hemost 2015; 41(01): 099-107
DOI: 10.1055/s-0034-1398385

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Hemostasis and Thrombosis in Major Liver Resection

Andrea J. Cross

¹Department of Surgery, Christchurch Hospital, Christchurch, New Zealand

,

Saxon J. Connor

¹Department of Surgery, Christchurch Hospital, Christchurch, New Zealand

› Author Affiliations

Abstract

The liver plays an important role in the balance between hemostasis and thrombosis. Hepatic resection, particularly when performed in the presence of underlying parenchymal liver disease, can cause perturbation of this balance. This review summarizes the changes that occur in normal hemostasis and thrombosis before, during, and after nontransplant hepatic resection and, wherever possible, provides strategies for the perioperative management of bleeding and thrombosis.

Keywords

liver resection - hemostasis - thrombosis

Full Text

References

References
1 Foster JH. Survival after liver resection for cancer. Cancer 1970; 26 (3) 493-502
2 Ekberg H, Tranberg KG, Andersson R , et al. Determinants of survival in liver resection for colorectal secondaries. Br J Surg 1986; 73 (9) 727-731
3 Zimmitti G, Roses RE, Andreou A , et al. Greater complexity of liver surgery is not associated with an increased incidence of liver-related complications except for bile leak: an experience with 2,628 consecutive resections. J Gastrointest Surg 2013; 17 (1) 57-64 , discussion 64–65
4 Rees M, Tekkis PP, Welsh FK, O'Rourke T, John TG. Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg 2008; 247 (1) 125-135
5 Siu J, McCall J, Connor S. Systematic review of pathophysiological changes following hepatic resection. HPB (Oxford) 2014; 16 (5) 407-421
6 Esmon CT. The protein C pathway. Chest 2003; 124 (3, Suppl): 26S-32S
7 Esmon CT. Coagulation and inflammation. J Endotoxin Res 2003; 9 (3) 192-198
8 Vasse M. Protein Z, a protein seeking a pathology. Thromb Haemost 2008; 100 (4) 548-556
9 Wada H, Usui M, Sakuragawa N. Hemostatic abnormalities and liver diseases. Semin Thromb Hemost 2008; 34 (8) 772-778
10 Ferland G, Sadowski JA, O'Brien ME. Dietary induced subclinical vitamin K deficiency in normal human subjects. J Clin Invest 1993; 91 (4) 1761-1768
11 Çakır T, Cingi A, Yeğen C. Coagulation dynamics and platelet functions in obstructive jaundiced patients. J Gastroenterol Hepatol 2009; 24 (5) 748-751
12 Ben-Ari Z, Panagou M, Patch D , et al. Hypercoagulability in patients with primary biliary cirrhosis and primary sclerosing cholangitis evaluated by thrombelastography. J Hepatol 1997; 26 (3) 554-559
13 Pihusch R, Rank A, Göhring P, Pihusch M, Hiller E, Beuers U. Platelet function rather than plasmatic coagulation explains hypercoagulable state in cholestatic liver disease. J Hepatol 2002; 37 (5) 548-555
14 Papadopoulos V, Filippou D, Manolis E, Mimidis K. Haemostasis impairment in patients with obstructive jaundice. J Gastrointestin Liver Dis 2007; 16 (2) 177-186
15 Kennedy TJ, Yopp A, Qin Y , et al. Role of preoperative biliary drainage of liver remnant prior to extended liver resection for hilar cholangiocarcinoma. HPB (Oxford) 2009; 11 (5) 445-451
16 Lisman T, Caldwell SH, Burroughs AK , et al; Coagulation in Liver Disease Study Group. Hemostasis and thrombosis in patients with liver disease: the ups and downs. J Hepatol 2010; 53 (2) 362-371
17 Tripodi A, Salerno F, Chantarangkul V , et al. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology 2005; 41 (3) 553-558
18 Nuttall GA, Brost BC, Connis RT , et al; American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology 2006; 105 (1) 198-208
19 Lisman T, Leebeek FWG. Hemostatic alterations in liver disease: a review on pathophysiology, clinical consequences, and treatment. Dig Surg 2007; 24 (4) 250-258
20 Mannucci PM. Abnormal hemostasis tests and bleeding in chronic liver disease: are they related? No. J Thromb Haemost 2006; 4 (4) 721-723
21 Massicotte L, Beaulieu D, Thibeault L , et al. Coagulation defects do not predict blood product requirements during liver transplantation. Transplantation 2008; 85 (7) 956-962
22 O'Shaughnessy DF, Atterbury C, Bolton Maggs P , et al; British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol 2004; 126 (1) 11-28
23 Massicotte L, Lenis S, Thibeault L, Sassine M-P, Seal RF, Roy A. Effect of low central venous pressure and phlebotomy on blood product transfusion requirements during liver transplantations. Liver Transpl 2006; 12 (1) 117-123
24 Søgaard KK, Horváth-Puhó E, Grønbaek H, Jepsen P, Vilstrup H, Sørensen HT. Risk of venous thromboembolism in patients with liver disease: a nationwide population-based case-control study. Am J Gastroenterol 2009; 104 (1) 96-101
25 Senzolo M, Sartori MT, Lisman T. Should we give thromboprophylaxis to patients with liver cirrhosis and coagulopathy?. HPB (Oxford) 2009; 11 (6) 459-464
26 Lee AYY, Levine MN. Venous thromboembolism and cancer: risks and outcomes. Circulation 2003; 107 (23) (Suppl. 01) I17-I21
27 Falanga A, Panova-Noeva M, Russo L. Procoagulant mechanisms in tumour cells. Best Pract Res Clin Haematol 2009; 22 (1) 49-60
28 Falanga A, Marchetti M, Vignoli A. Coagulation and cancer: biological and clinical aspects. J Thromb Haemost 2013; 11 (2) 223-233
29 Lyman GH, Khorana AA, Falanga A , et al; American Society of Clinical Oncology. American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. J Clin Oncol 2007; 25 (34) 5490-5505
30 Srivastava A, Brewer AK, Mauser-Bunschoten EP , et al; Treatment Guidelines Working Group on Behalf of The World Federation Of Hemophilia. Guidelines for the management of hemophilia. Haemophilia 2013; 19 (1) e1-e47
31 Kokudo T, Uldry E, Degrauwe S, Demartines N, Halkic N. A successful case of right hepatectomy in a patient with von Willebrand disease. Haemophilia 2014; 20 (2) e191-e192
32 Buchanan GS, Rodgers GM, Ware Branch D. The inherited thrombophilias: genetics, epidemiology, and laboratory evaluation. Best Pract Res Clin Obstet Gynaecol 2003; 17 (3) 397-411
33 Lille S, Blackstone R. Inherited thrombophilias: are they an important risk factor in bariatric and post-bariatric surgery?. Bariatric Times 2008; ; Available at: http://bariatrictimes.com/inherited-thrombophilias-are-they-an-important-risk-factor-in-bariatric-and-post-bariatric-surgery/ . Accessed January 13, 2015
34 Kujovich JL, Factor V Leiden Thrombophilia. In: Pagon RA, Adam MP, Ardinger HH. , et al. eds. Gene Review, 2010. University of Washington, Seattle (WA). Available online at http://www.ncbi.nlm.nih.gov/books/NBK1368/
35 Huntington JT, Royall NA, Schmidt CR. Minimizing blood loss during hepatectomy: a literature review. J Surg Oncol 2014; 109 (2) 81-88
36 Gurusamy KS, Pamecha V, Sharma D, Davidson BR. Techniques for liver parenchymal transection in liver resection. Cochrane Database Syst Rev 2009; (1) CD006880
37 Gurusamy KS, Li J, Sharma D, Davidson BR. Pharmacological interventions to decrease blood loss and blood transfusion requirements for liver resection. Cochrane Database Syst Rev 2009; (4) CD008085
38 Gurusamy KS, Li J, Vaughan J, Sharma D, Davidson BR. Cardiopulmonary interventions to decrease blood loss and blood transfusion requirements for liver resection. Cochrane Database Syst Rev 2012; 5 (5) CD007338
39 Strasberg SM, Belghiti J, Clavien PA , et al. The Brisbane 2000 terminology of liver anatomy and resections. HPB 2000; 2: 333-339
40 Ishizaki Y, Yoshimoto J, Miwa K, Sugo H, Kawasaki S. Safety of prolonged intermittent pringle maneuver during hepatic resection. Arch Surg 2006; 141 (7) 649-653 , discussion 654
41 Belghiti J, Noun R, Zante E, Ballet T, Sauvanet A. Portal triad clamping or hepatic vascular exclusion for major liver resection. A controlled study. Ann Surg 1996; 224 (2) 155-161
42 Simillis C, Li T, Vaughan J, Becker LA, Davidson BR, Gurusamy KS. Methods to decrease blood loss during liver resection: a network meta-analysis. Cochrane Database Syst Rev 2014; 4 (4) CD010683
43 Koea JB, Batiller J, Patel B , et al. A phase III, randomized, controlled, superiority trial evaluating the fibrin pad versus standard of care in controlling parenchymal bleeding during elective hepatic surgery. HPB (Oxford) 2013; 15 (1) 61-70
44 Cauchy F, Gaujoux S, Ronot M , et al. Local venous thrombotic risk of an expanding haemostatic agent used during liver resection. World J Surg 2014; 38 (9) 2363-2369
45 Rees M, Plant G, Wells J, Bygrave S. One hundred and fifty hepatic resections: evolution of technique towards bloodless surgery. Br J Surg 1996; 83 (11) 1526-1529
46 Cunningham JD, Fong Y, Shriver C, Melendez J, Marx WL, Blumgart LH. One hundred consecutive hepatic resections. Blood loss, transfusion, and operative technique. Arch Surg 1994; 129 (10) 1050-1056
47 Melendez JA, Arslan V, Fischer ME , et al. Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: blood loss, blood transfusion, and the risk of postoperative renal dysfunction. J Am Coll Surg 1998; 187 (6) 620-625
48 Rahbari NN, Koch M, Zimmermann JB , et al. Infrahepatic inferior vena cava clamping for reduction of central venous pressure and blood loss during hepatic resection: a randomized controlled trial. Ann Surg 2011; 253 (6) 1102-1110
49 Uchiyama K, Ueno M, Ozawa S , et al. Half clamping of the infrahepatic inferior vena cava reduces bleeding during a hepatectomy by decreasing the central venous pressure. Langenbecks Arch Surg 2009; 394 (2) 243-247
50 Luo L-X, Yu Z-Y, Bai Y-N. Laparoscopic hepatectomy for liver metastases from colorectal cancer: a meta-analysis. J Laparoendosc Adv Surg Tech A 2014; 24 (4) 213-222
51 Lochan R, Ansari I, Coates R, Robinson SM, White SA. Methods of haemostasis during liver resection—a UK national survey. Dig Surg 2013; 30 (4-6) 375-382
52 Bezeaud A, Denninger MH, Dondero F , et al. Hypercoagulability after partial liver resection. Thromb Haemost 2007; 98 (6) 1252-1256
53 Kobayashi S, Yokoyama Y, Matsushita T , et al. Increased von Willebrand Factor to ADAMTS13 ratio as a predictor of thrombotic complications following a major hepatectomy. Arch Surg 2012; 147 (10) 909-917
54 Shontz R, Karuparthy V, Temple R, Brennan TJ. Prevalence and risk factors predisposing to coagulopathy in patients receiving epidural analgesia for hepatic surgery. Reg Anesth Pain Med 2009; 34 (4) 308-311
55 Weinberg L, Scurrah N, Gunning K, McNicol L. Postoperative changes in prothrombin time following hepatic resection: implications for perioperative analgesia. Anaesth Intensive Care 2006; 34 (4) 438-443
56 Siniscalchi A, Begliomini B, De Pietri L , et al. Increased prothrombin time and platelet counts in living donor right hepatectomy: implications for epidural anesthesia. Liver Transpl 2004; 10 (9) 1144-1149
57 Matsukawa M, Kaikita K, Soejima K , et al. Serial changes in von Willebrand factor-cleaving protease (ADAMTS13) and prognosis after acute myocardial infarction. Am J Cardiol 2007; 100 (5) 758-763
58 De Pietri L, Montalti R, Begliomini B , et al. Thromboelastographic changes in liver and pancreatic cancer surgery: hypercoagulability, hypocoagulability or normocoagulability?. Eur J Anaesthesiol 2010; 27 (7) 608-616
59 Tapper EB, Tanaka KA, Sarmiento JM. Evaluation of hemostatic factors in patients undergoing major hepatic resection and other major abdominal surgeries. Am Surg 2011; 77 (9) 1188-1193
60 Giovannini I, Chiarla C, Giuliante F, Vellone M, Nuzzo G. Modulation of plasma fibrinogen levels in acute-phase response after hepatectomy. Clin Chem Lab Med 2004; 42 (3) 261-265
61 Meijer C, Wiezer MJ, Hack CE , et al. Coagulopathy following major liver resection: the effect of rBPI21 and the role of decreased synthesis of regulating proteins by the liver. Shock 2001; 15 (4) 261-271
62 Luddington RJ. Thrombelastography/thromboelastometry. Clin Lab Haematol 2005; 27 (2) 81-90
63 Barton JS, Riha GM, Differding JA , et al. Coagulopathy after a liver resection: is it over diagnosed and over treated?. HPB (Oxford) 2013; 15 (11) 865-871
64 Pulitanò C, Aldrighetti L, Arru M , et al. Preoperative methylprednisolone administration maintains coagulation homeostasis in patients undergoing liver resection: importance of inflammatory cytokine modulation. Shock 2007; 28 (4) 401-405
65 Pulitanò C, Aldrighetti L, Arru M , et al. Prospective randomized study of the benefits of preoperative corticosteroid administration on hepatic ischemia-reperfusion injury and cytokine response in patients undergoing hepatic resection. HPB (Oxford) 2007; 9 (3) 183-189
66 Neal CP, Mann CD, Garcea G, Briggs CD, Dennison AR, Berry DP. Preoperative systemic inflammation and infectious complications after resection of colorectal liver metastases. Arch Surg 2011; 146 (4) 471-478
67 Richardson AJ, Laurence JM, Lam VWT. Use of pre-operative steroids in liver resection: a systematic review and meta-analysis. HPB (Oxford) 2014; 16 (1) 12-19
68 Tzeng C-WD, Katz MHG, Fleming JB , et al. Risk of venous thromboembolism outweighs post-hepatectomy bleeding complications: analysis of 5651 National Surgical Quality Improvement Program patients. HPB (Oxford) 2012; 14 (8) 506-513
69 Weiss MJ, Kim Y, Ejaz A , et al. Venous thromboembolic prophylaxis after a hepatic resection: patterns of care among liver surgeons. HPB (Oxford) 2014; 16 (10) 892-898
70 Morris RJ, Woodcock JP. Evidence-based compression: prevention of stasis and deep vein thrombosis. Ann Surg 2004; 239 (2) 162-171
71 Comerota AJ, Chouhan V, Harada RN , et al. The fibrinolytic effects of intermittent pneumatic compression: mechanism of enhanced fibrinolysis. Ann Surg 1997; 226 (3) 306-313 , discussion 313–314
72 Roderick P, Ferris G, Wilson K , et al. Towards evidence-based guidelines for the prevention of venous thromboembolism: systematic reviews of mechanical methods, oral anticoagulation, dextran and regional anaesthesia as thromboprophylaxis. Health Technol Assess 2005; 9 (49) iii-iv , ix–x, 1–78
73 Urbankova J, Quiroz R, Kucher N, Goldhaber SZ. Intermittent pneumatic compression and deep vein thrombosis prevention. A meta-analysis in postoperative patients. Thromb Haemost 2005; 94 (6) 1181-1185
74 Geerts WH, Bergqvist D, Pineo GF , et al; American College of Chest Physicians. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133 (6, Suppl): 381S-453S
75 Tzeng C-WD, Curley SA, Vauthey JN, Aloia TA. Distinct predictors of pre- versus post-discharge venous thromboembolism after hepatectomy: analysis of 7621 NSQIP patients. HPB (Oxford) 2013; 15 (10) 773-780
76 Leonardi MJ, Hollander LL, Pitt HA , et al. Acute Portomesenteric Venous Thrombosis Following Abdominal Surgery: Observe, Anticoagulate or Operate?. Conference proceedings for The Society for Surgery of the Alimentary Tract; 2011
77 Sobhonslidsuk A, Reddy KR. Portal vein thrombosis: a concise review. Am J Gastroenterol 2002; 97 (3) 535-541
78 Thomas RM, Ahmad SA. Management of acute post-operative portal venous thrombosis. J Gastrointest Surg 2010; 14 (3) 570-577
79 Plessier A, Darwish-Murad S, Hernandez-Guerra M , et al; European Network for Vascular Disorders of the Liver (EN-Vie). Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study. Hepatology 2010; 51 (1) 210-218
80 Amitrano L, Guardascione MA, Scaglione M , et al. Prognostic factors in noncirrhotic patients with splanchnic vein thromboses. Am J Gastroenterol 2007; 102 (11) 2464-2470